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ABSTRACT 
 
Rebecca A. Driver, for the Master’s in Science degree in Rehabilitation Counseling at 
Southern Illinois University Carbondale.  
 
TITLE: U.S. SOCIETY AND THE EVOLVING NEEDS OF THE BABY BOOMER 
GENERATION AS IT RELATES TO ALZHEIMER’S DISEASE 
 
MAJOR PROFESSOR:  Dr. Thomas Upton 
 
The Baby Boomer generation, those born between the years 1946-1964, are beginning 
to reach the age of when symptoms of initial onset of Alzheimer’s Disease become 
prevalent. This causes a concern for society in the United States due to the high 
number of persons that make up this generation that are likely to significantly increase 
the already high number of Alzheimer’s Disease cases in the United States. Causes for 
concern include the high number of people within this generation reaching age of initial 
onset of Alzheimer’s disease, the impact the disease as a whole on individuals, as well 
as their families, caregivers, and society. While there is no cure for the progression of 
Alzheimer’s disease currently, research into the development of a cure has been 
deemed a priority. There are growing concerns of the level of care available to the 
elderly population and the lack of diagnosis in the early stages of the disease. Research 
presents resolutions for society, that when implemented, can alleviate some of these 
concerns. Further research into the alleviation of the current and future concerns that 
the Baby Boomer Generation generates for United States’ society is discussed. 
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CHAPTER 1 
INTRODUCTION 
 
The study looks into contemporary U.S. society and assesses if the evolving 
needs of persons and families for the aging population with Alzheimer's disease. The 
purpose of this study is to look into the effects that the Baby Boomer generation will 
have on United States society, current concerns and future concerns that AD imposes, 
recent solutions, and possible solutions in the future.   
Looking into the generational information, it is estimated that 79 million people 
were born in the United States between the years 1946 and 1964 (Goldsmith, 2011). 
This generation is known as the “Baby Boomers”, and is one of the largest generations 
that have been seen thus far in the history of the United States (Goldsmith, 2011). The 
people who are from the start of the Baby Boomer generation have just surpassed the 
age of 65 (Goldsmith, 2011). According to a report by the Alzheimer's Association, an 
estimate of 1 in 8 people of this generation develops Alzheimer's disease or dementia 
after the age of 65 (Goldsmith, 2011). Looking at such a high number of people who 
make up the Baby Boomer generation, and having 1 in 8 people developing this 
condition, this adds up to around 10 million people of this generation developing 
Alzheimer's or dementia (Goldsmith, 2011). 
Currently, there are an estimated 5.3 million people with Alzheimer's disease in 
the United States (Goldsmith, 2011). That number is expected to double, and by 2050 
can be likely to hit 16 million people (Goldsmith, 2011). The impacts that Alzheimer's 
currently has on this country is already high, but by 2050 with the number of Alzheimer's 
cases on the rise, the impacts will be colossal (Goldsmith, 2011). Not only are the costs 
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significant, but also the physical and emotional toll that the disease takes on the 
individual as well as the family. It is of great importance to look into the effects that this 
disease currently has, and will have, on society.  
Background 
Current concerns related to this study include that there is no cure for 
Alzheimer's disease at this time (Goldsmith, 2011). Researchers, scientists, and the 
government have deemed finding a cure for the degenerative brain disorder that 
typically begins later in life of great importance in the United States (Wierenga & Bondi, 
2011).   Being that this disease slowly takes away memory and therefore the ability for a 
person to care for themselves, it takes a large toll on the person themselves (Goldsmith, 
2011). When a person is no longer able-bodied and cannot care for themselves, the 
responsibility lies in the hands of family members, friends, or outside care givers 
(Goldsmith, 2011). One of the major concerns currently is the financial impact that this 
disease has not only for the individual, but also for the family and society (Goldsmith, 
2011).  
It is important for society and people within the healthcare fields to become 
aware of the growing concerns due to the large number of people that make up the 
Baby Boomer generation and the effects that Alzheimer's disease will have on not only 
the generation itself, but also on society as a whole. Within the fields that students 
study, each have a primary focus which can include working with people from birth to 
old age. When students and/or workers have a primary focus on the younger 
generations, they may not have the opportunity to learn about the concern of this age 
group and the impacts that it will have on society entirely. Awareness is of upmost 
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importance, as well as investigating and resolving the unresolved concerns of this 
subject. 
Significance of the Study 
Being that awareness and resolving the current concerns that this disease will 
have on society is of upmost importance, it is evident that there is a need to look into 
these concerns in depth and consider what may be potential possibilities to resolving 
these concerns. There are many concerns about the subject of Alzheimer's disease as 
a whole, especially with the Baby Boom generation starting to make up the older 
population in the United States. With the age of onset of Alzheimer's disease and those 
of the Baby Boomer generation meeting these ages of onset, there is high concern of 
how to care for a vast number of cases that is expected to rise significantly. 
 There are also concerns that there is still not a cure or a treatment that can 
prevent the progression of Alzheimer's disease. There is a very significant need for 
further research to find a treatment, and for the funding for this research to possibly one 
day find a preventative drug to prevent Alzheimer's disease from taking the lives of 
many people in the United States every year. The United States is currently faced with 
an issue that will impact individuals with Alzheimer's disease, and also their families and 
caregivers, and society as a whole. It is necessary for the effects of Alzheimer's disease 
on society to be looked at closely, and to find measures that can help resolve these 
effects and concerns that it poses.  By putting forward research collected from the 
literature, it can provoke others within the healthcare and rehabilitation field to expand 
and hopefully gain resolution to one or more of the current concerns that are presented 
to today's society. 
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Purpose  
  The purpose of this research is to identify how significant of an impact that 
Alzheimer’s Disease and the Baby Boomer generation will have on society as a whole, 
and to see what has been done and has been proposed to be carried out in the future to 
provide possible solutions to this impact. To approach this, I will look into the effects on 
the individual with Alzheimer's disease, families and caregivers, and on society as a 
whole. I will look into current research within the last five years to provide awareness on 
solutions that have been brought forward as well as possible solutions that can help to 
alleviate these future concerns. Research databases such as EBSCOhost and 
AcademicSearch Premier will be utilized, and the review of literature from various peer 
reviewed scholarly journals will be carried out to identify the information necessary for 
this research matter.  
Definition of Terms 
Upon providing a review of literature that was researched for the means of 
completing this paper, medical terms as well as the names of government programs are 
discussed. Clarification of terminology may be of benefit to those reviewing this review 
of literature.  
Medicaid: a government program that pays for specific health services and nursing 
home care for the elderly (Simmons, 2011). Medicaid is the primary public payer for 
long-term care (Simmons, 2011). 
Medicare: a federal health insurance program for those sixty-five or older, individuals 
with end-stage renal disease, and some people with disabilities (Tierney, 2013). To be 
eligible, age, special conditions, employment are all considered (Tierney, 2013). 
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Medicare was passed as a part of the Social Security Act of 1965, and is intended to 
give financial protection to older adults to protect them from the elevated cost of illness 
and hospitalization (Tierney, 2013).  
 
Degenerative Brain Disorder:  A disorder caused by the decrease of nervous system 
cells, or neurons (“Degenerative Brain Diseases,” 2014). The disorder is progressive, 
and as the brain decays over time, an individual loses intellectual function including 
speech, memory, and spatial skills (“Degenerative Brain Diseases,” 2014).  
 
Formal Care: Care provided by staff including nurses and care workers, who are paid, 
and work in care settings such as hospitals, care homes, or in patients’ homes (“Formal 
Care of People with Dementia,” 2014).  
 
Informal Care: Care provided by family members, friends, and/or neighbors, who are 
unpaid, that give regular, continuous assistance to an individual (“Informal Carer,” 
2013).  
 
Long Term Care: A variety of services and support services that assist with activities of 
daily living such as toileting, housework, money management, caring for pets, shopping 
for everyday needs, and taking medication (“What is Long-Term Care,” 2014) 
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CHAPTER 2 
REVIEW OF THE LITERATURE 
 
Overview of Organization of Chapter 
Chapter two reviews Alzheimer’s disease and the impacts of the Baby Boomer 
generation. The next section covers the current economic impacts of Alzheimer's 
disease to the individual and families and caregivers of individuals with Alzheimer's 
disease. Through this section, there is a focus on the impacts of formal care versus 
informal care. The review of the literature will continue with focusing on the economic 
impacts that Alzheimer's disease has on society as a whole due to the evolving needs 
of the Baby Boomer generation. After reviewing the impacts that Alzheimer's disease 
has not only on the individual of the Baby Boomer generation and their caregivers and 
families, but also on society, the review will focus on current research on the disease as 
well as on possible treatments that has been conducted as a result of these impacts. 
Finally, current solutions striving towards alleviating these impacts and solutions that will 
be carried out in the future will be looked at closely. The review of literature will 
conclude with solutions being targeted to alleviate the concerns of the Baby Boomer 
generation and the prevalence of Alzheimer's disease.  
Etiology and Prevalence 
Dementia is defined as a group of disorders that involve the pervasive, 
progressive, and irreversible deterioration of cognitive functioning due to an array of 
causes (Hamdy et al., 2013). In the United States, Alzheimer’s disease is the most 
common form of dementia (Moschetti et al., 2012). AD affects an estimated 5.3 million 
people in the United States (George, Whitehouse, & Ballenger, 2011), and makes up 
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60-80 percent of all dementias (Carterville et al., 2012). Without effective treatments for 
Alzheimer's disease and other dementias, an estimated 16 million Americans will be 
affected by 2050 (Attea & Johns, 2010).  
Alzheimer’s disease (AD) is an upcoming public health disaster (Cummings, 
Ringman, & Metz, 2010), and is a major cause of disability and dependence for older 
adults (Casey, 2012). Every 70 seconds someone in the United States progresses to 
meeting the criteria for diagnosis of AD (Cummings, Ringman, & Metz, 2010).  
Research shows that with the advancing age of the baby boom generation, that 
by 2050, 14-16 million older Americans are estimated to have AD (Wierenga & Bondi, 
2011) (Attea & Johns, 2010). In 2012, the first cohort of 76 million people who are of the 
Baby Boomer generation who were born between 1946 and 1964 began to turn 65 
(Yang et al., 2012). With the five million people in the United States who currently have 
AD, and the aging “baby boomer” population is expected to add 10 million individuals to 
this calculation (Cummings, Ringman, & Metz, 2010). 
AD is an age-related degenerative brain disorder (Wierenga & Bondi, 2011). The 
main clinical manifestation of AD is a progressive global dementia syndrome that 
normally starts later in life (Wierenga & Bondi, 2011). Terms such as early-, mid-, and 
late-stage AD are terms used to measure the progression of AD (Simmons, 2011). Early 
stage AD is characterized by the individual no longer being able to function 
independently (Simmons, 2011). In mid-stage AD, the individual will show major gaps in 
memory as well as a compelling decline in cognitive function and personality changes 
may begin to be seen as well (Simmons, 2011). In the late stages of AD, many 
individuals no longer have the ability to verbally communicate, although some may be 
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able to recall a few words (Simmons, 2011). There is also apparent severe physical 
decline (Simmons, 2011).  
Memory loss and cognitive decline, which are seen at the earliest point of AD, 
may be misconstrued by caregivers as normal symptoms of the aging process (Leifer, 
2009). In the later stages of AD, people have the inability to carry out everyday tasks 
such as basic activities of daily living (Leifer, 2009). Activities of daily living include 
eating and bathing by oneself (Leifer, 2009). Also, people diagnosed with AD may show 
neuropsychotic symptoms including delusions, depression, and agitation at any point 
during the progression of the disease (Leifer, 2009). 
On a biological standpoint, AD is described as a clinicopathological state which 
literally means the ‘loss of the ability to think’ (Shan, 2013). Patients show progressive 
cognitive failure including the loss of the ability to form and retrieve new memories, 
change in personality, and losing the ability to navigate in familiar environments (Shan, 
2013). Common symptoms of AD are behavioral, and eventually individuals with AD 
require 24 hour care and hands-on assistance with activities of daily living (7).  
AD and many other dementias are progressive and over time, are fatal, and no one 
currently survives these diseases (Attea & Johns, 2010).  
From 2000-2006, the death rate of AD increased 46 percent, while other major 
causes of death decreased (Attea & Johns, 2010). This figure is in part due to the 
advancement of recognition and willingness by doctors and families to report that AD 
was the cause of death (Attea & Johns, 2010). Also, as deaths from other diseases and 
causes continue to decrease, more Americans are living longer to develop and die from 
AD (Attea & Johns, 2010).  
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The greatest risk factor for AD is age, and the likelihood of developing AD 
increased from an estimated 1 percent in adults age 60 years to around 45 percent for 
those ages 85 and older (Wierenga & Bondi, 2011). Being susceptible to AD has also 
been found to be related to genetic risk factors (Wierenga & Bondi, 2011).Many times, 
AD goes undiagnosed until it has progressed to the debilitating stages of the disease 
which may play into the fact that less than half of people with the disease are diagnosed 
currently with AD (Leifer, 2009). 
Impacts to the Individual, Families and Caregivers 
Research has found that for families who provide care for family members 
diagnosed with Alzheimer’s disease will face out of pocket expenses that will increase 
by 400 percent (Goldsmith, 2011). Providing care whether within an institution or at 
home, using paid or unpaid services is costly for a person with Alzheimer’s disease (Fox 
& Max, 2009).  
Fidelity Investment estimated that for a 65 year old couple retiring in 2009, they 
would require upwards of $500,000 to cover medical expenses for retirement if one 
spouse was diagnosed with AD (“Planning Around Alzheimer’s,” 2009). This estimate is 
more than double the cost it would take to cover medical expenses if neither one was 
diagnosed with AD or another major disease (“Planning Around Alzheimer’s,” 2009).  
Impacts of Formal Care  
Direct costs that can include physician services, hospital care, nursing home 
care, medication, adult daycare, homemaker services, respite care, transportation 
services, and other services are all costs that an individual with Alzheimer’s disease and 
caregivers are bound to face (Fox & Max, 2009). It is more likely for a person with 
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Alzheimer’s disease who is a Medicare beneficiary to utilize inpatient hospital services 
and see a physician than with those without the diagnosis (Fox & Max, 2009).  A study 
conducted in 2002 showed that the health care costs for individuals with and without AD 
and other dementias are greater in patients with AD than in control individuals due to 
the higher utilization of inpatient and skilled nursing facilities (Leifer, 2009). 
In June 2009, Harvard University and the American Association of Homes for the 
Aging (AAHA) conducted a study on sustainable housing for the aging (Simmons, 
2011). The study found that the average monthly rate for assisted living facilities that 
charge additional fees for Alzheimer’s disease and care for individuals with dementia is 
$4,270 monthly or $51,240 per a year (Simmons, 2011).  
Impacts of Informal Care 
The burden has been shifted from the formal paid caregiving system to the 
informal unpaid caregiving system (Fox & Max, 2009). This shift has allowed for federal 
and state programs to save money, but without the assistance of caregivers, the 
financial cost to public programs would significantly increase (Fox & Max, 2009).  
The setting where those diagnosed with AD live is important in determining whether the 
care they receive will be informal or formal, and who will take on the economic burden 
of being a provider of that care (Fox & Max, 2009). Research had found that the cost of 
providing care for those with AD in the community entails unpaid informal care which 
accounts for three-quarters of the overall cost (Fox & Max, 2009). On the other hand, 
twelve percent of the cost of care for people who are receiving care within an institution 
is for unpaid informal care (Fox & Max, 2009). 
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While it may seem that financially it is less costly to keep a person diagnosed 
with AD residing in the home, it is clear that the economic burden of home care is 
evident (Fox & Max, 2009). Research has found that most of the expenses for caring for 
those with AD at home are taken care of by families (Fox & Max, 2009). Studies show 
that the cost of informal care and value of caregiving that is unpaid is immense, and 
ranges from two to three times the value of paid formal care (Fox & Max, 2009). 
Delaying institutionalization may result in the saving of cost to public programs like 
Medicaid that pays for care in skilled nursing facilities (Fox & Max, 2009). On the other 
hand, it can shift the burden of care onto family caregivers for a longer period of time 
(Fox & Max, 2009). In turn, the direct costs would be minimized, but the overall social 
costs would be maximized (Fox & Max, 2009).  
Many unpaid caregivers report positive effects of caregiving (Attea & Johns, 
2010). However, many also experience significant levels of depression, and emotional 
and serious negative effects on their health, employment, and financial security (Attea & 
Johns, 2010).  Family and friends who provide care for those living with Alzheimer’s 
disease need support for the continuation of providing care to allow those with cognitive 
impairments to reside in the home and avoid being institutionalized (Fox & Max, 2009).  
The indirect costs of the disease also include the value of days that the individual with 
the Alzheimer’s disease diagnoses lost, the value of informal caregiver services by 
family members and friends that did not receive wages, and the costs of physical and 
emotional suffering that those with the disease and their families experience. However, 
those costs are many times rarely, if ever, calculated (Fox & Max, 2009).  
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Economic Impacts of AD on Society  
Studies have shown that Alzheimer’s disease poses an emotional and economic 
burden on those with the diagnosis, their caregivers, professionals providing services, 
and on society (Fox & Max, 2009) Society is faced with the economic cost of 
Alzheimer’s disease in terms of all goods and services that are implemented for the 
prevention, diagnosis, treatment, and care of people with Alzheimer’s disease (Fox & 
Max, 2009). As of 2011, U.S. healthcare costs such as long-term care, health care, and 
hospice services totaled $183 billion with Medicare and Medicaid covering an estimated 
70% of these figures (Moschetti et al., 2012). 
Society is directly impacted by the cost of research as it relates to the diagnosis, 
treatment, causes, the course of Alzheimer’s disease, as well as the cost of educating 
the public about the disease (Fox & Max, 2009). The National Institutes of Health 
spends an estimated two-thirds of a billion dollars a year on Alzheimer’s related 
research (Fox & Max, 2009). Studies have found that the cost to Medicare to provide 
care to someone with Alzheimer’s disease will hike up more than 600 percent 
(Goldsmith, 2011).  
AD poses a burden that will continue in the future (Goldsmith, 2011). The U.S. 
economy will face financial impacts that will excessive (Goldsmith, 2011).  The annual 
cost to society for Alzheimer’s disease has been estimated to surpass $1 trillion by 2051 
(Goldsmith, 2011). The financial cost to society and individuals with AD is forecasted to 
increase rapidly due to the aging population and those who are responsible for the 
planning and financing of health care face the difficulty of using the increasingly scarce 
resources against the current and future interventions aimed towards AD (Shearer et 
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al., 2012). AD is likely to overcome the resources that society can use to assist in the 
care of elderly individuals in the United States (Cummings, Ringman, & Metz, 2010). 
Estimating the economic impact and cost to society for Alzheimer’s disease is 
important for many reasons (Fox & Max, 2009). It is important to assess the magnitude 
that the disease impacts society as it relates to other major diseases (Fox & Max, 
2009). Also, it is important for the public to raise awareness of the impact that AD has 
for the purpose of advocacy by placing an economic value on unpaid and paid care 
(Fox & Max, 2009). Likewise, it is important for policy makers to be informed of the need 
for health services in order to address AD. Finally, it is important to value the 
contribution of the labor by informal caregivers (Fox & Max, 2009). The total cost of AD 
on society is increasing due to the higher number of people living with the diagnosis of 
AD with the aging population living longer (Fox & Max, 2009). 
People with dementia make up one-quarter of older customers of paid homecare 
services, and nearly one-half of customers of adult daycare, residential care, and skilled 
nursing facility care (Fox & Max, 2009). Alzheimer’s disease also involves indirect costs 
that use resources (Fox & Max, 2009). People with AD who have severe impairments 
receive more formal and informal care than people with AD who have mild to moderate 
impairment, regardless if they are residing in the community or in a nursing home (Fox 
& Max, 2009). Based on current estimations of the prevalence rate of dementia and the 
cost of the care of dementia found in cross sectional studies, the National Institutes of 
Health (NIH) and the Alzheimer’s Association believe that the increased size of 
population and extended longevity will advance to significant increases in dementia 
cases among the Baby Boomer generation (Yang et al., 2012). Data shows that this 
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could increase to as many as double the cases, and can surge the societal cost of 
dementia care that could go to upwards of $20 million over the course of the next 40 
years (Yang et al., 2012).  
Research suggests that the cost of dementia care should be defined as a 
longitudinal cost over the course of the disease (Yang et al., 2012). A person diagnosed 
with AD for a shorter time before death at an older age may cost either more or less to 
society than with a patient with a continued course of the disease that begins at a 
younger age (Yang et al., 2012).  
Current Research on AD 
Current research has not found whether or not AD can be prevented (Shan, 
2013). Technological progress is being done to find early detection that can give the 
chance for those with a family history of AD to be attentive about symptoms and take 
advantage of available assessments early on (Shan, 2013). 
Research on Factors Associated with AD 
However, research shows that there are factors that are associated with AD 
(Shan, 2013). Smoking and consuming alcohol increases the risk of AD (Shan, 2013). 
Studies show that being overweight or obese is associated as well (Shan, 2013). The 
higher the body mass index, BMI, the higher the risk of AD (Shan, 2013). Psychosocial 
factors have also been found to be associated with AD such as education and 
socioeconomic status. The lower that socioeconomic status, research shows the higher 
risk a person is to developing AD (Shan, 2013). Social network and social engagement 
is associated with the likelihood of developing AD as well. Having poor networking and 
engagement has been found to lead to reduced cognitive function and dementia (Shan, 
15 
 
 
2013). Likewise, social isolation leads to a higher risk of developing the disease (Shan, 
2013). Physical activity has been found to delay the onset of dementia and AD (Shan, 
2013). Studies also have found that mental activity has a protective effect against the 
development of dementia and AD (Shan, 2013).  
Research has also found that dietary factors like the Mediterranean diet or the 
consuming of antioxidants, polyunsaturated fatty acids, cereals, vegetables, and 
omega-3 fatty acid minimize the incidence of dementia in population and observational 
studies (Aprehamian & Forlenza, 2013).  Likewise, participating in activities that engage 
stimulation mentally, socially, and physically may delay the onset of dementia 
(Aprehamian & Forlenza, 2013). Maximized frequency of cognitive engagement may 
reduce the risk of dementia and also explain the relation between education and AD risk 
(Aprehamian & Forlenza, 2013). 
Current Concerns of the Level of Care for the Growing Older Population 
As the population ages, the social, economic, and personal costs of dementia are 
increasing (Casey, 2012). The quality of services being delivered in a long-term care 
setting is of upmost importance in offering adequate living for individuals with AD 
(Simmons, 2011). The long-term care system faces many difficulties (Simmons, 2011).  
Population growth in people age 85 and older and other changes in society will 
boost demand for long-term care by 2030 (Simmons, 2011). This demand will lead to 
challenges in the current system that include low workforce retention, quality issues, 
lack of technology, and a significant reliance on out-of-pocket and Medicaid funding 
(Simmons, 2011). Current challenges will become more severe if they are not 
addressed (Simmons, 2011), including that funding is significantly lower than funding for 
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research for other diseases with alike or less effect in terms of prevalence, morbidity, 
mortality, and costs (Attea & Johns, 2010). 
The Alzheimer’s Association feels that much more is necessary to improve care 
for individuals with AD (Attea & Johns, 2010). A problem of great significance is under 
detection and diagnosis (Attea & Johns, 2010). Research has found that less than half 
of all individuals with dementia in the United States have a diagnosis of AD in their 
primary care medical record (Attea & Johns, 2010). Reasons for this may be due to the 
challenge of detecting dementia in routine care visits, insufficient time with the physician 
and reimbursement for diagnostic evaluations, some lack of knowledge of physicians on 
how to carry out diagnostic evaluation for dementia, lack of approval for evaluation by 
individuals, individual and family concerns regarding the stigma related to the diagnosis 
of dementia, and physician doubt of the value of diagnosing an individual with AD if they 
feel there is “nothing they can do” (Attea & Johns, 2010). 
These factors are not the only issue (Attea & Johns, 2010). Numerous individuals 
with AD and their families do not receive many kinds of care and services available to 
them to assist them with their needs (Attea & Johns, 2010). These services include 
ongoing medical management to assist in maintaining the individual’s physical health 
and functioning, medical management, coordination of primary and specialty medical 
care, information and education associated with community care; information, 
consultation, and support for families to assist with caregiving needs, and information 
and support during peak stress situations like hospitalizations and making decisions 
regarding residential care, concerns of safety, and end-of-life concerns (Attea & Johns, 
2010). 
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There are many factors associated with why they are not receiving these care 
and service options (Attea & Johns, 2010). There are an inadequate number of 
geriatricians and other physicians who have been trained to detect and diagnose AD 
and manage care for individuals with AD (Attea & Johns, 2010). Also, insufficient 
physician time and reimbursement for care planning, care coordination, and family 
consultation and support (Attea & Johns, 2010). Some physicians reported that they are 
not knowledgeable enough about possible valuable community services and how to 
assist families with caregiver tasks (Attea & Johns, 2010). 
Policy makers, researchers, and scientists have made the quality of elderly care 
of priority (Simmons, 2011). As the older population in the United States increases 
significantly, more families are facing the challenge of providing quality care for the 
elderly person in the home (Simmons, 2011). Even after realizing they need 
professional help, families are often reluctant to send a member of the family to an 
institution for long-term care due to feelings of guilt and concerns about the treatment of 
their family member (Simmons, 2011). 
Due to AD, individuals with this diagnosis need a substantial amount of care, 
patience, and understanding (Simmons, 2011). The need for professionals in the 
workforce who are well-trained is a major part of what is being addressed about 
sustainable living (Simmons, 2011). Besides challenges with financing and service 
delivery, providers and consumers experience difficulty bringing in and maintaining 
paraprofessional workers to assist people who need long term care (Simmons, 2011). 
  There is a shortage of paraprofessional workers, who are certified nursing aides 
in nursing homes and home care aides, and is currently a critical concern for providers 
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of long-term care (Simmons, 2011). Currently, there is difficulty in finding staff, not only 
as administrators, but also as direct and indirect caregivers that have the ability to 
perform professionally within their specialties as well as developing positive 
relationships with residents and other members of staff (Simmons, 2011). 
With research that has been conducted up to this point, it has still remained a 
significant challenge for clinicians and researchers to prevent AD (Aprehamian & 
Forlenza, 2013). There has been recent emphasis on focusing on identifying possible 
modifiable risk factors for dementia, including interventions designed to promote 
cognitive engagement, physical activities, nutrition, as well as the increase in 
antihypertensive medication use (Aprehamian & Forlenza, 2013). 
Another concern with AD and the care of the aging population is that in 2005, 
there was one geriatrician for every 5,000 Americans 65 and older. Only nine medical 
schools in the United States have departments of geriatrics, out of 145 (Simmons, 
2011). Very few schools have geriatric courses requirements (Simmons, 2011), 
hospitals allow for internists to graduate with as little as six hours of geriatric training 
(Simmons, 2011).  
Current Research on Treatment of AD 
The U.S. Food and Drug Administration (FDA) have given approval to five 
medications to assist in the treatment of symptoms of AD, but there are no current 
approved treatments that can prevent or cure AD (Attea & Johns, 2010).  Studies have 
found many benefits for early treatment and being persistent in implementing those 
methods of treatment (Leifer, 2009). Research has found that detecting AD early may 
assist in improving outcomes like cognition, function, and behavior (Leifer, 2009).   
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Even though there is no current disease-modifying drug therapy approved for 
AD, there is emphasis placed on identifying people in the pre-clinical stage so that as 
strategies of treatment are developed, they can be used during the earliest period of AD 
when they are most effective (Aprehamian & Forlenza, 2013). Recognizing and 
diagnosing AD early provides individuals and families with an option to plan for the 
future while the patient still has the opportunity to be a part of the process (Leifer, 2009). 
Numerous drug therapies are being investigated for potential use for people with AD 
and include donepezil, rivastigmine, galantamine, memantine, ginkgo biloba, and 
vitamin B12/folate (Fox & Max, 2009).  
Currently, ChEls are the approved therapy drug for mild-to-moderate AD (Leifer, 
2009). Numerous studies have been carried out looking at the safety and efficiency of 
donepizel, rivastigmine, and galantiamine (Leifer, 2009). Studies have concluded that 
ChEls are an effective treatment for AD in the mild-to-moderate stages (Leifer, 2009). 
ChEls assist with the cognitive, functional, and behavioral symptoms that appear during 
the mild-to-moderate stages of AD (Leifer, 2009).  
Likewise, another study was conducted with the study of rivastigmine over the 
course of 26 weeks (Leifer, 2009). Over the duration of the study, patients who received 
rivastigmine experienced a minor decline below baseline. However, patients who 
received placebo showed a much more significant decline (Leifer, 2009).  Individuals 
with AD should be encouraged to be persistent with treatment if possible (Leifer, 2009).  
A study was also done looking at the effectiveness of donepezil which showed 
that a washout break from therapy for 6 weeks showed results of unrecoverable losses 
in function (Leifer, 2009). With the current treatments that are available, long-term 
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sustained improvements may be a vast expectation (Leifer, 2009). In pharmacotherapy 
of AD, giving the opportunity to stabilize the symptoms and delaying further decline are 
of primary importance of treatment (Leifer, 2009). 
There are many pharmacologic treatments for AD; however individuals with AD 
are many times not prescribed one of the cholinesterase inhibitors that have been 
approved to treat mild-to-moderate AD or all stages of AD (Leifer, 2009). Likewise, the 
Nmethyl D-aspartate receptor antagonist memantine, which has been approved for the 
treatment of moderate-to-severe AD, is also many times not prescribed (Leifer, 2009). A 
community-based study found that out of 2114 individuals with mild-to-moderate AD 
who were a part of the study, only 35% were prescribed one of these approved 
treatments (Leifer, 2009). 
Drugs that have been developed that may treat AD have had limited success 
when used in trials (Casey, 2012). By understanding these limitations, it allows nurses 
to support patients with AD as well as the family with education about treatment options 
(Casey, 2012). The reason for treatment is to delay AD from progressing and may not 
result in improving the symptoms of AD (Leifer, 2009). For example, a 5 month study 
was conducted that treated patients with AD with galantamine which as a result showed 
very little improvement (Leifer, 2009). However, patients that were given the placebo 
resulted in having a decline in Neuropsychiatric Inventory score (Leifer, 2009). What this 
study shows is that for a healthcare practitioner who is treating an individual with AD, it 
may seem as if the treatment is not effective, when the treatment results in preservation 
of function over time (Leifer, 2009). 
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Current Solutions by National Associations 
The Alzheimer’s Association is the largest private funder of research, and has 
been calling for the federal government to expand funding for Alzheimer’s disease 
research (Goldsmith, 2011). The mission of the Alzheimer’s Association is to eliminate 
AD and related dementias through research, maximization of care and support for those 
affected, and minimizing the risk of dementia by promoting brain health (Attea & Johns, 
2010). The Alzheimer’s Association is a voluntary health association with over 70 
chapters in the world (Attea & Johns, 2010). The association provides funding to 
research; provides information, support, and services to those with Ad and other 
dementias as well as their caregivers; and carries out public information campaigns to 
raise awareness of AD and related dementias (Attea & Johns, 2010).  
The Alzheimer’s Association also advocates at the federal, state, and local levels 
for funding research (Attea & Johns, 2010). Also, they advocate with the American 
Geriatrics Society, for public policies to advance services and care for individuals with 
AD (Attea & Johns, 2010). In 2011, the budget for research of Alzheimer’s disease was 
$480 million (Goldsmith, 2011). The Alzheimer’s Association has stressed that partially 
because of funded research by the government; the death rates for a number of major 
diseases have decreased significantly (Goldsmith, 2011) 
The Alzheimer’s Association has proposed that Medicare coverage and 
reimbursement impose a package of primary care services. These services include 
routine procedures for the detection of possible AD in primary care offices and clinics, 
diagnostic evaluation, and initial care planning over a four month period following 
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diagnosis and documenting the diagnosis and plan of care in the individual’s medical 
record (Attea & Johns, 2010). 
In the past few years and throughout the healthcare reform debate, advocacy for 
care coordination has been targeted (Attea & Johns, 2010). Working closely with the 
American Geriatrics Society, the Alzheimer’s association has advocated for government 
policies and programs to boost coordination between primary and specialty medical 
care. Likewise, they have also advocated increasing coordination between medical and 
nonmedical settings and providers (Attea & Johns, 2010). These policies and programs 
are important and beneficial for people with AD and related dementias due to cognitive 
impairment and inability to coordinate their own care (Attea & Johns, 2010). The 
Alzheimer’s Association encourages the U.S. Congress, state legislatures, and federal, 
state, and local government agencies and policies to advance care and services for 
those with AD and related dementias (Attea & Johns, 2010). 
The Alzheimer’s Association offers a 24/7 helpline for those with AD and their 
families and caregivers (Attea & Johns, 2010). The helpline is staffed with informational 
specialists and master’s level counselors who give information, education, consultation, 
support, and community referrals to those with AD and their families and caregivers 
(Attea & Johns, 2010). The local chapter follows up with these individuals on the 
following business day to give continued information, support, and referrals for services 
that are necessary (Attea & Johns, 2010). The Alzheimer’s Association also gives public 
information programs and numerous training programs for care providers (Attea & 
Johns, 2010). 
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Current Solutions by the Government 
In January of 2011, President Obama deemed AD a national priority by signing 
into law the National Alzheimer’s Project Act (NAPA) (1). The act will create a 
coordinated national plan to assist in the overcoming of the AD crisis and will target the 
coordination and evaluation of national efforts of AD research, clinical and institutional 
care, home and community based programs and the outcomes (1). 
The healthcare reform law that has recently been enacted includes care 
coordination provisions that will be beneficial for those with AD, and includes transitional 
care and medical home programs, care coordination pilot projects, and policies to 
reduce hospitalizations that are unnecessary (Attea & Johns, 2010). Other provisions 
from the healthcare reform that will boost care for those with AD include increased 
federal funding for geriatrics training, a national long-term care insurance program, and 
increased federal payments for Medicaid home and community services (Attea & Johns, 
2010). 
President Obama’s administration recently announced the plan to boost federal 
funding for AD research and disease management which highlights the importance of 
this health concern to the public (Moschetti et al., 2012).  This announcement indicates 
the immense need for more cost-effective, evidence- based clinical, community, and 
public health interventions (Moschetti et al., 2012). The research is intensely focused on 
the treatment, detection, and prevention of AD (Shearer et al., 2012). Currently, the 
federal government contributes over $25,000 to assist in the care of those with the 
Alzheimer’s disease for every $100 they put towards Alzheimer’s research (Goldsmith, 
2011).  
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Future Solutions for Individuals with AD, Their Families and Caregivers, and 
Society 
According to Goldsmith 2011, society must become more educated about AD. 
The public can put in place strategies that research has shown to delay AD symptoms, 
increase brain health, and cognitive function (1). The National Institute on Aging 
recommends that mental stimulation, social engagement, physical exercise, and a 
healthy diet that includes antioxidants (1). The Division of Aging implements these 
components into their programs and services (1).  
For those who strive to maintain brain health for as long as possible, research 
shows that staying active and mentally curious is beneficial (Leifer, 2009). The 
Alzheimer’s Association came out with the “maintain your brain” initiative which 
suggests that reading, writing, working crossword puzzles, playing board games, 
gardening, staying physically and socially active, and maintaining a brain-healthy low 
fat, low cholesterol, and high levels of dark colored fruits and vegetables may all be 
ways to do so (Leifer, 2009).  
Carrying out these activities will need to be suited to an individual considering 
their level of cognition. This will also change as AD progresses in the individual (Leifer, 
2009). Other factors that are beneficial to individuals with AD as the disease progresses 
are providing a safe environment for the individual and minimizing stimulation in excess 
(Leifer, 2009). 
For each symptom that may become expressed during the progression of the 
disease, many tips are available for caregivers (Leifer, 2009). With indecisiveness, the 
caregivers are encouraged to reduce choices (Leifer, 2009). If an individual with AD is 
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showing disorientation, the caregiver is encouraged to provide cues, avoid relocation, 
and possibly bring items that are familiar to the individual (Leifer, 2009).  If 
hallucinations are present, the caregiver should not be overly concerned as long as they 
are not distressing to the individual, but if treatment is necessary, antipsychotic agents 
can be considered (Leifer, 2009). However, the family and caregivers of the individual 
must be fully informed of the risks as well as the benefits of these medications (Leifer, 
2009). If the caregivers notice wandering, which typically occurs in moderate-to-severe 
AD, later in the progression of the disease, it is suggested that the family or caregivers 
register them in the Medic Alert and Safe Return Program, make the environment 
secure with complex handles, and to inform neighbors (Leifer, 2009). 
Future Solutions for Medical Treatment 
There is urgency for the development of new drugs with disease-modifying 
properties for AD (Aprehamian & Forlenza, 2013). A disease modifying drug is defined 
as a pharmaceutical agent that is intended to slow the progression of the 
neurodegenerative process by inhibiting crucial events in the pathophysiology of AD, 
which constricts that pathological load (Aprehamian & Forlenza, 2013). 
AD presents a particular problem to an ageing society due to the cost of care and the 
progression towards effective treatments that can prevent the advancement or reversal 
of AD to provide a noteworthy quality of life for as long as possible (Casey, 2012). 
Investigating the best care options will continue to be of importance until sufficient 
progress can be made on the nature of AD, its pathogenesis and treatments, or a cure 
(Casey, 2012). 
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When treatment can be given and is successful, it can reverse or even slow the 
decline of cognition associated with AD (Fox & Max, 2009). This in turn can delay the 
need for institutionalization and significantly minimize the need for informal care due to 
the improvement of functioning for a person with AD (Fox & Max, 2009). There is a push 
to attempt to convince policy makers that putting a drug on the Medicaid formulary will 
results in long-term-care savings for the population of people with the diagnosis of AD 
(Fox & Max, 2009). This could result in reducing the costs to programs such as 
Medicare and Medicaid (Fox & Max, 2009). 
Future Solutions Regarding Early Detection of AD 
Early detection may assist in reducing costs related to AD treatment (Leifer, 2009). 
Nursing home care is the most expensive component of caring for an individual with AD 
(Leifer, 2009). In turn, delaying placement into a nursing home can help to lower the 
cost of managing AD (Leifer, 2009). A study was conducted to assess the relationship 
between treatment with donepezil and time of placement in a nursing home (Leifer, 
2009). The study showed that an individual being placed in a nursing home was 
delayed significantly for individuals using at least 5 mg/day of donepezil, and a 
cumulative dose-response relationship in delaying nursing home placement was 
observed in the persistent use of donepezil (Leifer, 2009). For individuals using 5 
mg/day or more of donepezil for a duration of 9-12 months, the delay of the initial 
placement of nursing home care for dementia was 21.4 months, and permanent 
placement into a nursing home was delayed for 17.5 months compared with individuals 
given less than 5 mg or less for a duration of 6 weeks (Leifer, 2009). 
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Future Solutions by National Associations 
Currently, Medicare covers and pays for specialty physician care such as 
diagnostic evaluations, and for some imaging tests (Attea & Johns, 2010). As an 
improvement, the Alzheimer’s Association is pursuing Congressional support and 
passage of the Alzheimer’s Breakthrough Act.  The Alzheimer’s Breakthrough Act asks 
for a $2 billion investment annually in Alzheimer’s research that would strengthen AD 
research as a priority of the National Institute on Aging (Attea & Johns, 2010). The act 
would also give $15 million for comprehensive awareness and education campaign 
efforts on AD and related dementias for health professionals and the public which would 
be led by the Centers for Disease Control and Prevention (Attea & Johns, 2010). 
Future Solutions Regarding Early Detection of AD 
Early detection may assist in reducing costs related to AD treatment (Leifer, 2009). 
Nursing home care is the most expensive component of caring for an individual with AD 
(Leifer, 2009). In turn, delaying placement into a nursing home can help to lower the 
cost of managing AD (Leifer, 2009). A study was conducted to assess the relationship 
between treatment with donepezil and time of placement in a nursing home (Leifer, 
2009). The study showed that an individual being placed in a nursing home was 
delayed significantly for individuals using at least 5 mg/day of donepezil, and a 
cumulative dose-response relationship in delaying nursing home placement was 
observed in the persistent use of donepezil (Leifer, 2009). For individuals using 5 
mg/day or more of donepezil for a duration of 9-12 months, the delay of the initial 
placement of nursing home care for dementia was 21.4 months, and permanent 
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placement into a nursing home was delayed for 17.5 months compared with individuals 
given less than 5 mg or less for a duration of 6 weeks (Leifer, 2009). 
Future Solutions for Physicians and Primary Care Providers 
Due to the burden of AD falling on families of individuals with AD, primary care 
providers are encouraged to monitor signs of caregiver stress and provide support 
(Leifer, 2009). Numerous strategies are available to be shared with caregivers, and 
include referrals to support groups and a local Alzheimer’s Association chapter (Leifer, 
2009).  
Primarily, individuals with the early stages of AD will first seek care in the primary 
care setting (Leifer, 2009). Primary care providers should be open to the signs and 
symptoms of AD since they are typically the first healthcare professionals that people 
with AD see (Leifer, 2009). There are many tools that assist clinicians in recognizing 
symptoms of AD and many treatments that may delay progression of those symptoms 
(Leifer, 2009).  
Early diagnosis of AD has several benefits (Leifer, 2009). Without a diagnosis, 
the behavior an individual with AD expresses may be a challenge for family members to 
understand (Leifer, 2009). Family members might put blame on the individual for 
behaving in a way that is beyond their control, and may have denial that there is indeed 
a medical problem (Leifer, 2009). An early diagnosis may allow for an increase of safety 
if members of the family are aware that activities like driving or cooking may be high risk 
for the individual with AD (Leifer, 2009). An individual with AD may have the opportunity 
to participate in financial and legal planning, advance directives, and to discuss long-
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term care options (Leifer, 2009). When a diagnosis has been made, the individual, their 
family or caregiver has the opportunity to start treatment (Leifer, 2009).  
Having a clearer understanding of treatments that are available and awareness 
that persistent and continuous treatment gives to individuals with AD through the 
moderate-to-severe stages of the disease, is necessary to ensure that these individuals 
are given optimal treatment and care throughout the duration of the disease (Leifer, 
2009). The expectations for treatment provided by clinicians should be realistic, and the 
expectations of the individual and their caregiver should be managed carefully to suit 
their needs (Leifer, 2009).  
The physician and other care professionals would provide the care planning 
(Attea & Johns, 2010). It would be carried out in collaboration with the patient, when 
possible, but would also utilize telephone counseling and in-person consultations with 
the family or caregivers of which Medicare does not currently cover if the individual is 
not present (Attea & Johns, 2010). 
Future Solutions by Future Research 
 AD research must increase adequately with the magnitude of the threat it poses 
to the US (Cummings, Ringman, & Metz, 2010). Research into how AD produces the 
effects in the brain and how to best address these effects in human therapeutics must 
be increased (Cummings, Ringman, & Metz, 2010). The UCLA-Easton Alzheimer’s 
Center plans to increase resources, collaborations, and productivity to discover and 
meet the scientific and social challenges that AD poses (Cummings, Ringman, & Metz, 
2010).  
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Future Solutions of Services and Support 
There is a need for immediacy for services and programs to provide assistance 
and support to informal caregivers (Fox & Max, 2009). By engaging people to 
understand and think about AD and conditions that are related to it, there can be further 
understanding of the disease, which can bring social change (Fox & Max, 2009). By the 
public taking into account that the “phenomena of altered states of consciousness can 
teach lessons about living and giving that are as valuable and important as our 
everyday or “normal” way of being, then we may then begin to perceive different options 
for addressing the needs of people with AD and those who care for them that transcend 
the approaches that have shaped the Alzheimer’s policy discourse in America” (Fox & 
Max, 2009).  
An approach to AD that takes into account not only the discovery for medications 
but also possible long-term-care strategies is extremely important, according to Fox & 
Max, 2009. This is due to the fact that people are being given an AD diagnosis earlier in 
the beginning stages of AD than previously before (Fox & Max, 2009). According to Fox 
& Max 2009, if the general public begins to think in these terms, then it is possible to 
shed light on how to provide the best care for those with AD and other disabilities that is 
cognizant of the social and medical needs of a person (Fox & Max, 2009). Likewise, 
there are rehabilitative measures that can be taken to assist with the needs of 
individuals with AD (Leifer, 2009). These measures include developing and 
implementing a daily routine that is predictable, simplifying tasks, and giving the 
opportunity for independence (Leifer, 2009). 
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The expectations of the individual with AD and their caregivers are encouraged 
to be managed carefully and discussed, and being referred to an AD support group is 
beneficial at this point in time (Leifer, 2009). It is also necessary for the long-term care 
system to explore innovations to better the mix of financing and to improve delivery to 
enhance the services that are being provided to long-term care consumers and their 
families (Simmons, 2011).  
With the aging of the baby boomer generation, housing developers are going to 
be attentive to the physical design of homes, and may be more pressured to build 
homes in which people can age in place (Simmons, 2011). The overall trend is steering 
away from institutional and medical-based models (Simmons, 2011). The trend is 
towards a social, community based, residential, or home-like models (Simmons, 2011). 
Consumers are increasing a demand for more opportunities in options of care 
(Simmons, 2011). 
It is vital that owners and administrators understand what their management and 
staffs responsibilities are and how to identify if they are being implemented accurately 
(Simmons, 2011). They should give clear job descriptions and job responsibilities, have 
a system for the observation and matching performance with what is expected, hold 
staff accountable for performance, give regular feedback, and use those results to 
identify and correct practice and performance concerns (Simmons, 2011). The delivery 
in care being carried out properly would allow for staff and practitioners to predict 
concerns more accurately and to explain to an individual and their family information 
about the care being received (Simmons, 2011). 
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Many long-term quality initiatives are attempting to better the quality of care and 
life for elderly individuals in the care of long-term facilities (Simmons, 2011). One 
initiative is to encourage the transformation and medical institutional settings to home-
like settings that place emphasis on privacy, choice, and a feeling of well-being 
(Simmons, 2011).  
 Likewise, Quality First, is another initiative that is the first national initiative that 
asks providers to achieve excellence in the quality of care and services for elderly 
individuals (Simmons, 2011). Another initiative is Advancing Excellence in America’s 
Nursing Homes, which brings together providers, government agencies, and consumers 
to encourage quality by setting goals that are measureable for providers (Simmons, 
2011).  
The long-term care system needs to ensure a vigorous supply of professional 
and paraprofessional workers and address challenges recruiting, training, and retaining 
these workers (Simmons, 2011). If there is no change, these challenges will worsen and 
have a negative effect on consumers (Simmons, 2011). The long-term care system has 
many goals including ensuring safety, preventing injuries, and enhancing the quality of 
care and the quality of life of individuals in their care (Simmons, 2011). The government, 
providers, consumers, and long-term care healthcare professionals need to address 
quality issues that are in the system currently (Simmons, 2011). Implementing 
advanced technology will enhance the quality of care and independence of their 
patients as well as care management and care coordination (Simmons, 2011). 
Long-term care mainly targets maintaining or improving the ability of the elderly 
with disabilities like AD, to function as independently as possible (Simmons, 2011). 
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Social and environmental needs are also part of long-term care (Simmons, 2011). Long-
term care is available in a range of settings and what the individual and their caregivers 
choose is dependent on the individual’s needs and preferences, availability of informal 
support, and the reimbursement source (Simmons, 2011).  
Providing competent and motivated employees ongoing training in interactive 
relations with their patients, training in ethics, and training in delivering care in a positive 
environment is crucial with successful management of communities for people with AD 
(Simmons, 2011). Employees in the long-term setting need the authority and 
responsibilities to make decisions about the care residents receive (Simmons, 2011). 
 In long-term care, an individual should have the ability to continue to live life on 
their terms and to be provided with an appropriate level of care including with 
unanticipated needs of the individual (Simmons, 2011). It is important that caregivers 
maintain a professional attitude and have knowledge of how each individual’s cultural 
background continues to influence their present attitudes and behaviors (Simmons, 
2011). Personalized assessment tools assist the caregivers in knowing an individual’s 
personality and preferences as well as their changing needs (Simmons, 2011).  
Future Solutions by the Government 
Since the Patient Protection and Affordable Care act was passed, the U.S. health 
care system has been going through many changes (Yang et al., 2012). There have 
been some policy interventions that target lifestyle change and are under consideration 
(Yang et al., 2012). For example, the YMCA version of the Diabetes Prevention 
Program nationally might minimize Medicare spending by an estimated $50 billion 
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across the whole Baby Boomer cohort by preventing chronic diseases that are 
associated to obesity (Yang et al., 2012).  
Proposals of financial reform of Medicare and Medicaid and new service models 
are being considered as well (Yang et al., 2012). Suggestions such as changing 
Medicare hospice care guidance to be based on the care of the patients’ need instead 
of estimated life expectancy and the proposition of Program for All-inclusive Care for the 
Elderly model to encourage comprehensive care for elderly who become frail (12). 
Further studies in regards to the cost effectiveness of these policy recommendations will 
allow for valuable insights (Yang et al., 2012). 
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CHAPTER 3 
DISCUSSION 
 
The impacts of AD due to the aging baby boomer population have raised 
concerns for the future. Currently, AD affects around 5.3 million people in the United 
States, and by 2050 is projected to directly impact another 10 million individuals of the 
baby boomer generation.  
Being that AD is an age-related degenerative brain disorder, it is characterized 
by progressively manifesting a decline in cognitive and physical function, personality, 
memory, and neuropsychotic symptoms over the course of time for an individual with 
the disease. Due to the effects that AD projects onto an individual, it is necessary for 
those who enter the later stages of AD receive 24 hour care and direct assistance with 
activities of daily living. 
 The greatest factor playing into AD is age, and the chances of developing AD 
symptoms are approximately 1 percent in adults age 60 to 45 percent of those age 85 
and older. This is important to note with the baby boomer generation starting to hit 65 
years of age, when onset of AD is becoming prevalent.  
 There are many concerns that not only individuals with AD face, but also their 
families/caregivers, medical doctors, primary care providers, and society as a whole. 
Individuals and their families and caregivers face high cost of care and significant 
impacts to their own well-being, whether if formal care or informal care is chosen as a 
method of care services. The cost and value of unpaid service that families and 
caregivers provide is rarely calculated and taken into account the amount of the costs. 
AD many times goes without being diagnosed until the later and debilitating stages. 
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 As mentioned above, not only do individuals with AD and their families and 
caregivers face significant impacts due to AD, but so does society. Society faces an 
economic burden with the costs of the research, goods, and services for preventing, 
diagnosing, treatment, and care of those with AD. The economic impacts are not 
coming to a halt in the near future. It has been estimated that the financial cost to 
individuals as well as society is bound to increase dramatically due to the aging 
population. 
 It is of great importance to understand the economic impact and cost to society 
that AD will have because of the impacts to society, public awareness, advocacy, 
awareness of policy makers, and to be aware of the contribution that informal caregivers 
provide to those with AD. 
 So far, researchers have not been able to establish whether or not AD is 
preventable. However, research has found there are factors that increase the likelihood 
of an individual developing AD including lifestyle, socioeconomic and education status, 
and dietary factors. 
 Currently, there are many concerns in regards to the level of care that is being 
provided for the older population. These concerns are only projected to get more severe 
if these issues are not addressed and solutions are not made. Due to the aging 
population increasing rapidly, there will be a significant increase in demand for long-
term care by 2030. There are current issues standing such as low workforce retention, 
issues of quality, lack of technology, and a reliance on out-of-pocket and Medicaid 
funding. 
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 Another concern is the under detection and diagnosis of AD which is prevalent in 
the United States. Research has found that this may be due to a variety of reasons 
including the current difficulty of detecting dementia during routine visits. Along with the 
concern of under detection and diagnosis, many individuals and families are not being 
provided with the many services and opportunities for care that are available. The 
reasons for this significant problem are due to the lack of knowledge of some physicians 
on possible community services of value and how to assist families with caregiver tasks. 
When it does come to long-term-care, there is an excessive need for professionals and 
paraprofessionals to care for this population and to have appropriate training to do so.  
 While there have been five medications approved to assist in treating AD, there 
is still no cure or preventative drug therapy. However, research has found that there are 
significant benefits of early detection of AD. Even with this breakthrough in research, it 
is still imperative that a preventative drug therapy be developed to stop the progression 
of AD. 
 There are many things being done currently to address these concerns and push 
towards finding solutions. The Alzheimer’s Association plays a major part in finding 
answers too many of the concerns earlier stated. The association pushes for funding 
from the federal government, conducts research, maximizes opportunities for care and 
support, and educates the public on awareness. The Alzheimer’s Association has also 
made proposals to better current federal programs such as Medicaid.   
The government is also addressing these concerns and taking a stand in finding 
ways to alleviate these concerns. In the past few years, laws have been signed to assist 
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in finding answers to the prevention of AD by funding research and addressing the need 
for care.  
While there has been some progress in striving to find answers to the concerns 
that AD poses with the baby boomer generation, there are many things that society as a 
whole is pushed to become aware of and implement. When it comes to individuals with 
AD and their families and caregivers, there are many things that they can do in the 
future. There are many recommendations of lifestyle habits and activities that 
individuals can carry out to assist in the delay of onset of AD. For families and 
caregivers that are assisting an individual who has already displayed symptoms of AD, 
there are many strategies that are suggested to assist with the care and in turn can 
assist with caregiver stress. 
 It is imperative for a drug with disease-modifying properties of AD to be 
developed in the future. If such a drug is developed, it can reverse or slow the 
progression of cognitive decline which would delay the need for an individual to be 
institutionalized and for informal caregiving to require. 
Further research needs to be conducted on the current treatments and 
appropriate dosages that would delay the need for long term care and informal 
caregiving. The Alzheimer’s Association is pushing for funding further future research 
on these issues and others. 
There is a push in the future for early detection of AD, which may reduce the 
costs that are associated with treating AD.  Along with early detection of AD, primary 
care providers are being encouraged to look for signs of caregiver stress and provide 
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support. Numerous strategies are available for caregivers, and referrals may be made 
to support groups to assist their needs. 
There is a significant need for an understanding of available treatment, and the 
effects that persistent treatment has on an individual with the disease. Primary care 
providers need to lay out realistic treatment expectations, and in a fashion that suits the 
needs of each individual case. In the future, doctors are being pushed to be a part of 
care planning to assist the needs of their patients. 
In the future, it will be imperative that services and programs are available for 
supporting informal caregivers. There needs to be further understanding of AD, which 
can in turn bring social change. It is important for professionals and paraprofessionals 
within the long-term care setting to address the issues with training and the retention of 
workers.  
 Within the long-term care setting, and with the growing need for services for the 
baby boomer generation, it will be important for the settings to be based on a social, 
community based, and residential, home-like model. With the increase of demand for 
opportunities in care options, it will be imperative that these options be available as 
needed. 
 To further address the concern of the level of care being provided in long-term 
care facilities, there are needs that need to be met by owners and administrators. By 
giving clear job descriptions, job responsibilities, a system for observation and 
performance, holding staff accountable as well as giving feedback, there would be an 
opportunity for the advancement of current care.  
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Implications for Professionals 
 It is evident that there are evolving needs for the baby boomer generation as it 
relates to AD. With such high numbers of individuals rapidly becoming a part of the 
older population, it is imperative that the concerns that society faces be addressed. With 
the  10 million people that make up the baby boomer generation that are estimated to 
develop AD, there are many things that society need to do to prepare for the evolving 
needs that this imposes. There are many concerns, primarily relating to a lack of a 
disease-modifying drug and preventative medicine, the level of care older people are 
receiving, lack of awareness, lack of knowledge and training, and a lack of enough 
funding to generate the research needed to potentially come closer to finding an 
effective drug therapy. 
 It is important for professionals to be aware of the evolving needs for the baby 
boomer generation. The toll of such a high number of people requiring long term care 
and support services is dramatic. If enough funding can be implemented for future 
research to discover if there is an option for prevention, it can help lead to the discovery 
of a disease-modifying drug that will alleviate many of the other concerns that society 
faces.  
 The level of care within long term care facilities needs to be evaluated. The 
research shows that there are many ways to bettering these facilities and in turn will 
help alleviate individual as well as family and caregiver stress. If staff is properly trained 
and properly being oversaw by management and owners, then better care will be 
possible, which in turn may give families and caregivers more of a sense of peace with 
allowing their loved one to enter into long term care instead of being provided primarily 
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informal care. This would allow for less stress upon the families and caregivers and 
alleviate many of the concerns that they are currently facing. Another important 
implication that research shows is the importance of allowing individuals to have as 
much of a feeling of independence as long as possible. If this is implemented in the long 
term care setting, then this may also give caregivers and families a sense of peace. 
 Training and knowledge of AD, services and support available, and care 
management are all important when working with an individual with AD. Primary care 
providers need to be aware of not only the current treatments that can assist with 
symptoms of AD, but also resources where the individual and family and caregivers can 
receive support through the progression of the disease.  
Conclusions/Implications/Recommendations 
Research has found that there are many concerns that are facing U.S. society 
with the evolving needs for the baby boomer generation as it relates to AD. One of the 
important concerns that have been noted in the review of literature is a need for 
awareness and public education of AD and related dementias. There is also need for 
the public awareness of the concerns that AD poses. If people within the rehabilitation 
field as well as other healthcare fields become aware of this rising concern, it may bring 
about more of a desire for people to become more actively involved in assisting this 
population.  
 Also, if physicians and primary care providers become more aware of support 
services for individuals and their families and caregivers, they will be able to refer them 
to those who are rehabilitation counselors that will be able to provide support for 
individual stress as well as family/caregiver stress. People in turn will be able to learn 
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more about further services that can further assist them in the process of helping their 
loved ones. People who work in the field of rehabilitation will be able to do their part in 
assisting those affected by AD, and help to answer many concerns that society faces 
currently, as well as in the future.  
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